Thursday 12th, 19th and 26th October at 3pm BST / 4pm CET / 10am EDT Early diagnosis of cancer is […]
Peter Johnson, National Clinical Director for Cancer, NHS England
Biomarker detection is a fundamental requirement for early cancer detection. The rapidly developing field of multi-omics has the potential to […]
It is well established that detecting and diagnosing cancer earlier significantly improves patient outcomes. Therefore, the identification of cancer biomarkers […]
Drug discovery is a time-consuming and costly process, particularly given the high number of trials that ultimately “fail” or have […]
Original post by Liam Little in February 2023. Updated by Ashleigh Davey in September 2023. Cancer is a disease of […]
Liquid biopsy has seen a lot of development and many applications in the field of cancer diagnostics. Key applications include […]
Detecting early signs of disease is often crucial to achieving the best possible patient outcomes. To date, blood-based liquid biopsies have […]
Andy Sharrocks (Professor at The University of Manchester) joins us to discuss the epigenetics of esophageal adenocarcinoma, why studying epigenetics […]
Written by Lauren Robertson, Science Writer. Researchers from the University of Texas MD Anderson Cancer Center have revealed the largest […]
